Literature DB >> 24705476

[Pelvic lymph node dissection. Complication management].

D Weckermann1.   

Abstract

Extended pelvic lymph node dissection allows exact lymph node staging and has the potential to improve prognosis. In addition to these advantages, there are some perioperative and postoperative complications. In case of transection of the obturator nerve, a microsurgical end-to-end anastomosis should be performed. The most frequent postoperative complication is (symptomatic) lymphocele which is predominantly diagnosed after extraperitoneal surgery. Meticulous lymph node dissection with clipping of lymphatic vessels, sparing the lateral wall of the external iliac artery from dissection, sufficient postoperative drainage, and application of low molecular weight heparin in the upper arm may reduce their incidence. Instillation of sclerosing agents and sufficient drainage are normally successful. If not, laparoscopic fenestration of lymphocele should be performed. Regular ultrasound examinations are necessary to diagnose and treat postoperative lymphocele in a timely manner.

Entities:  

Mesh:

Year:  2014        PMID: 24705476     DOI: 10.1007/s00120-014-3480-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  27 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Robotic-assisted laparoscopic transection and repair of an obturator nerve during pelvic lymphadenectomy for endometrial cancer.

Authors:  Farr R Nezhat; Shao-Chun R Chang-Jackson; Uchenna C Acholonu; Patrick F Vetere
Journal:  Obstet Gynecol       Date:  2012-02       Impact factor: 7.661

3.  Laparoscopic injury and repair of obturator nerve during radical prostatectomy.

Authors:  Massimiliano Spaliviero; Andrew P Steinberg; Jihad H Kaouk; Mihir M Desai; Warren C Hammert; Inderbir S Gill
Journal:  Urology       Date:  2004-11       Impact factor: 2.649

4.  How can lymphocele development be prevented after laparoscopic radical prostatectomy?

Authors:  Yota Yasumizu; Akira Miyajima; Takahiro Maeda; Toshikazu Takeda; Masanori Hasegawa; Takeo Kosaka; Eiji Kikuchi; Mototsugu Oya
Journal:  J Endourol       Date:  2012-12-05       Impact factor: 2.942

5.  Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study.

Authors:  Jindong Ji; Hexing Yuan; Liangliang Wang; Jianquan Hou
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

6.  [Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy].

Authors:  B Rousseau; L Doucet; M-A Perrouin Verbe; G Papin; A Erauso; V Joulin; C Deruelle; A Valeri; G Fournier
Journal:  Prog Urol       Date:  2013-11-05       Impact factor: 0.915

7.  Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.

Authors:  Dorothea Weckermann; Robert Dorn; M Trefz; Theodor Wagner; Friedhelm Wawroschek; Rolf Harzmann
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

8.  Immediate grafting of transected obturator nerve during radical hysterectomy.

Authors:  Fatemeh Ghaemmaghami; Fariba Behnamfar; Hooshang Saberi
Journal:  Int J Surg       Date:  2008-09-19       Impact factor: 6.071

9.  Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.

Authors:  Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

10.  Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.

Authors:  Michael A Liss; Kerrin Palazzi; Sean P Stroup; Ramzi Jabaji; Omer A Raheem; Christopher J Kane
Journal:  World J Urol       Date:  2013-03-20       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.